DOCSF 2023: Novel Regenerative Drug Candidate for Osteoarthritis of the Knee

Discover groundbreaking insights on regenerative drug candidates for knee osteoarthritis in this episode of the Digital Orthopedics Podcast with Dr. Denis Evseenko. Challenging the conventional view of interleukin six (IL-6) as solely pro-inflammatory, Dr. Evseenko unveils its potential role in tissue regeneration. Drawing from a study in Science Translational Medicine, he discusses the exciting implications for clinical outcomes and details his research on leveraging inflammation's regenerative potential to combat osteoarthritis. By selectively blocking the destructive facet of inflammation while nurturing the regenerative aspect, promising preclinical outcomes have been achieved.Stay tuned to witness the progression of this innovative approach through upcoming clinical trials, unlocking new horizons in osteoarthritis treatment.

There are no comments yet.

Please log in to write the first comment.